510(k) Report

510(k) · Cleared

Recalled · Class II · 2026

NB3D Bone Void Filler

K132050510(k) TraditionalCleared Feb 7, 2014220-day reviewClass II21 CFR 888.3045Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Pioneer Surgical Technology, Inc. · MQV Filler, Bone Void, Calcium Compound

Cleared on Feb 7, 2014 as substantially equivalent to K111944 (Pioneer Surgical Technology, Inc., 2011) and 1 other predicate after a 220-day review. Its family tree reaches back 9 generations to 1996. It has been recalled once.

Decided
Feb 7, 2014
Review
220 days
Class
Class II
Product code
MQV
Recalls
1
Predicates
2

Its longest line of descent runs back 9 generations to K960978 (1996). 60 ancestors in all, the oldest K871773 (1987). No later device cites it as a predicate yet.

  1. Root · 9 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
  2. 5 generations between
  3. 3 generations backK071813 Mastergraft PuttyMedtronic Sofamor Danek · 2007
  4. 2 generations backK082166 Mastergraft StripMedtronic Sofamor Danek · 2009
  5. 1 generation backK111944 NB3D Bone Void FillerPioneer Surgical Technology, Inc. · 2011
  6. This deviceK132050 NB3D Bone Void FillerPioneer Surgical Technology, Inc. · 2014
Show all 9 generations
  1. Root · 9 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
  2. 8 generations backK980817 Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model…Interpore Intl. · 1998
  3. 7 generations backK000515 Pro Osteon 200R Resorbable Bone Graft Substitute, Models 2RG051…Interpore Cross Intl. · 2000
  4. 6 generations backK012751 Healos Bone Graft MaterialOrquest, Inc. · 2001
  5. 5 generations backK043308 Modification to: Healos Bone Graft MaterialDepuy Spine, Inc. · 2005
  6. 4 generations backK051386 Mastergraft Putty Bone Void FillerMedtronic Vascular · 2005
  7. 3 generations backK071813 Mastergraft PuttyMedtronic Sofamor Danek · 2007
  8. 2 generations backK082166 Mastergraft StripMedtronic Sofamor Danek · 2009
  9. 1 generation backK111944 NB3D Bone Void FillerPioneer Surgical Technology, Inc. · 2011
  10. This deviceK132050 NB3D Bone Void FillerPioneer Surgical Technology, Inc. · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K960978Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc1996—
−8K980817Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05…Interpore Intl.1998—
−7K000515Pro Osteon 200R Resorbable Bone Graft Substitute, Models 2RG051, 2RG101…Interpore Cross Intl.2000—
−6K012751Healos Bone Graft MaterialOrquest, Inc.2001—
−5K043308Modification to: Healos Bone Graft MaterialDepuy Spine, Inc.2005—
−4K051386Mastergraft Putty Bone Void FillerMedtronic Vascular2005—
−3K071813Mastergraft PuttyMedtronic Sofamor Danek2007—
−2K082166Mastergraft StripMedtronic Sofamor Danek2009—
−1K111944NB3D Bone Void FillerPioneer Surgical Technology, Inc.2011—
0 (this device)K132050NB3D Bone Void FillerPioneer Surgical Technology, Inc.2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198710
199210
199520
199710
199820
199910
200020
200140
200260
200370
200430
200590
200630
200740
200840
200910
FIG. 1 — Lineage of K132050, 1996–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K111944NB3D Bone Void Filler
Summary page 3
…Same as KI111944 and K(083033 Basic Design Same as KI 11944 Form Same as K111944 Performance Performed SE to K(083033 Manufacturing Principl…
Pioneer Surgical Technology, Inc.2011—
*K083033Vitoss Bone Graft Substitute, Bone Graft Substitute Filled Canister, Foam & Bioactive…
Summary page 1
…nel; Panel Code 87 Restorative Devices Branch Predicates: Ki 11944 NB3D Bone Void Filler (SE 11 -22-2011) K083033 Vitoss Bone Graft Substitute, Vitoss Bone Graft Substitute filled Canister, Vitoss Foam Bone Graft Subst…
Orthovita, Inc.2008—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Mar 9, 2026Class IIZ-1897-2026Incorrect or no expiration dateProducts were incorrectly labeled with a 5-year shelf life. The approved and validated shelf life is four years.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 8 companies; a new generation was cleared every 2.0 years on median.
  • 7 of the 60 ancestors have a recall of any class.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

NB3D is indicated for bony voids or gaps that are not intrinsic to the stability of the bony structures. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. NB3D is indicated to be gently packed into bony voids or gaps of the skeletal system (extremities and pelvis) un-hydrated or in conjunction with bone marrow aspirate or autogenous blood, or in the posterolateral spine in conjunction with bone marrow aspirate and autograft bone as a bone graft extender. The product provides a bone void filler that resorbs and is replaced with bone during the healing process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K132050: NB3D Bone Void Filler.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K132050

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026